Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients

Angel L.M. de Francisco,Javier Varas,Rosa Ramos,José Ignacio Merello,Bernard Canaud,Stefano Stuard,Julio Pascual,Pedro Aljama,P. Aljama,B. Canaud,A. L. M. de Francisco,Adelheid Gauly,José Luño,Francisco Maduell,Alejandro Martín Malo,JIgnacio Merello,Julio Pascual,Rafael Pérez García,Manuel Praga,R. Ramos,S. Stuard,J. Varas,Adam Zawada

Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients

2017

Long term inappropriate proton pump inhibitors use (PPIs) is a matter of concern, due to the risks associated with their long term use in chronic older patients. The risk of PPIs treatment in hemodialysis patients is unexplored.

Keywords:

Risk of mortality
Intensive care medicine
Hemodialysis
Medicine
Diabetes mellitus
Proton-pump inhibitor
medical care
Hypomagnesemia
Internal medicine
Concomitant
Population

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations